InsiderClue
Stocks · Health care · Services-Medical Laboratories

Quest Diagnostics

DGX Clue Score42
United States Fiscal year ends December CIK 0001022079 Results filed 22 Oct 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

37
Insider
Date
Role
Action
Shares
Price
Amount
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,907
$251.24
$730.35K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,877
$250.49
$720.65K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
3,004
$249.40
$749.21K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
2,358
$248.38
$585.69K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
1,151
$246.98
$284.28K
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
5,990
$246.26
$1.48M
Catherine T. Doherty
3 Nov 2026
Executive Vice President
Sold after exercise
3,818
$245.45
$937.14K
Gary M Pfeiffer
26 Oct 2026
Director
Sold on a plan
1,203
$243.00
$292.33K
J. E. Davis
1 Sep 2026
CEO and President
Sold on a plan
10,000
$242.72
$2.43M
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
430
$244.51
$105.14K
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
6,237
$243.63
$1.52M
Michael E Prevoznik
28 Aug 2026
SVP & General Counsel
Sold after exercise
16,010
$242.88
$3.89M
Mark E Delaney
28 Jul 2026
SVP & Chief Commercial Officer
Sold on a plan
1,600
$235.18
$376.29K
Karthik Kuppusamy
4 Jun 2026
SVP, Clinical Solutions
Sold after exercise
8,147
$200.00
$1.63M
J. E. Davis
1 Jun 2026
CEO and President
Sold on a plan
10,000
$194.14
$1.94M
Patrick Plewman
5 Mar 2026
SVP for Diagnostic Services
Sold on a plan
2,855
$206.21
$588.73K
Michael E Prevoznik
5 Mar 2026
SVP & General Counsel
Sold on a plan
3,878
$206.21
$799.68K
Catherine T. Doherty
5 Mar 2026
EVP, Regional Businesses
Sold on a plan
5,558
$206.21
$1.15M
Karthik Kuppusamy
4 Mar 2026
SVP, Clinical Solutions
Sell
2,628
$204.86
$538.37K
Patrick Plewman
3 Mar 2026
SVP for Diagnostic Services
Sold on a plan
410
$207.73
$85.17K
Michael E Prevoznik
3 Mar 2026
SVP & General Counsel
Sold on a plan
526
$207.73
$109.27K
Catherine T. Doherty
3 Mar 2026
EVP, Regional Businesses
Sold on a plan
632
$207.73
$131.29K
J. E. Davis
2 Mar 2026
CEO and President
Sold on a plan
10,000
$212.52
$2.13M
Catherine T. Doherty
19 Feb 2026
EVP, Regional Businesses
Sold on a plan
1,433
$204.83
$293.52K
Michael E Prevoznik
19 Feb 2026
SVP & General Counsel
Sold on a plan
1,111
$204.83
$227.57K
Patrick Plewman
19 Feb 2026
SVP for Diagnostic Services
Sold on a plan
958
$204.83
$196.23K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
351
$209.10
$73.39K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
1,619
$208.21
$337.09K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
3,500
$207.08
$724.79K
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
10,122
$206.37
$2.09M
Catherine T. Doherty
13 Feb 2026
EVP, Regional Businesses
Sold after exercise
10,573
$205.21
$2.17M
Patrick Plewman
10 Feb 2026
SVP for Diagnostic Services
Sold after exercise
5,662
$204.00
$1.16M
Vicky B Gregg
25 Nov 2025
Director
Sell
1,250
$191.76
$239.70K
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
4,747
$192.97
$916.04K
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
41,004
$192.27
$7.88M
J. E. Davis
25 Nov 2025
CEO and President
Sold after exercise
9,342
$191.59
$1.79M
Mark E Delaney
18 Nov 2025
SVP & Chief Commercial Officer
Sold after exercise
7,946
$187.35
$1.49M

What was left out

Form 4 filings counted 79
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 21
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 369,619
History held since 3 Oct 2006